To explore this further, here we describe the cGAS-STING signaling cascade and its extensive downstream activation channels, highlight some of the triggers for pathway activation, outline its diverse roles in carcinogenesis and anti-tumor immunity, and proposes some implications for its potential role in anti-cancer therapy. This evidence concerns the gene STING1 and cancer.